KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

DelveInsight's Macrophage Activation Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, macrophage activation syndrome emerging drugs, market share ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

New research reveals that aging immune cells can become locked in a self-sustaining inflammatory state, worsening the body’s ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor.

When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying severe pneumonia has remained a major research challenge. Although mouse ...